On November 1, 2013, ReposiTrak, Inc. ("ReposiTrak"), the food and drug safety venture between Park City Group, Inc. (the "Company") and Leavitt Partners, entered into an agreement with one of the world's largest supermarket trade associations. The agreement calls for ReposiTrak to be the exclusive solution provider of food and drug safety traceability services endorsed by the trade association. Management believes that this agreement establishes ReposiTrak as the industry standard system for food and drug safety tracking and tracing.

Management intends to discuss ReposiTrak's relationship with the Company and the joint marketing agreement in connection with certain internal and external meetings and presentations.

See Item 7.01 above.

This Current Report on Form 8-K may contain, among other things, certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, (i) statements with respect to the Company's plans, objectives, expectations and intentions; and (ii) other statements identified by words such as "may", "could", "would", "should", "believes", "expects","anticipates", "estimates", "intends", "plans" or similar expressions. These statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. In addition, the information contained herein is being furnished pursuant to Item 7.01 of Form 8-K, "Regulation FD Disclosure." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.